^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    mupadolimab (CPI-006)

    i
    Associations
    News

    Trials

    Company:
    Angel Pharma, Corvus Pharma
    Drug class:
    CD73 inhibitor
    Related drugs:
    Associations
    News

    Trials

    Apply
    CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers (NCT03454451)
    Phase 1
    Corvus Pharmaceuticals, Inc.
    Completed
    Last update posted :
    12/21/2023
    Initiation :
    04/25/2018
    Primary completion :
    12/28/2022
    Completion :
    02/19/2023
    MSI
    |
    Keytruda (pembrolizumab) • ciforadenant (CPI-444) • mupadolimab (CPI-006)